Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
doi:10.1080/15216540500163301 40
10K+ Happy Researchers What Researchers Say "Excellent quality peptides
Rhythm Pharmaceuticals, the developer of setmelanotide, has successfully pursued regulatory approval for the drug (marketed as IMCIVREE) in conditions caused by upstream defects in the MC4R pathway, such as POMC and LEPR deficiencies, where the receptor itself is intact, and the agonist mechanism is highly effective [57]
NDA submission The NDA package will include all preclinical data, Phase 1, 2, and 3 trial results, manufacturing information, proposed labeling, and risk management plans
For researchers who plan to titrate to higher doses , the 2mL reconstitution ratio is typically the best choice because it keeps all standard doses within the range of a single syringe draw
US$ 21.72
US$ 21.43
US$ 24.01
